SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER
- Determine the feasibility of providing group support, and evaluate the effect of
supportive-expressive group therapy vs. written educational material on the
psychological health and quality of life of men with stage I/II prostate cancer.
OUTLINE: Patients are stratified by prior hormonal therapy.
Patients continue standard oncologic treatment concurrently with supportive-expressive group
Supportive-expressive group therapy consists of twelve 90-minute weekly meetings with 8-12
members and 2 cotherapists and is based on the following themes: building bonds, expressing
emotions, detoxifying dying, taking time to prioritize and set realistic goals, fortifying
families, and dealing with doctors. Each session commences with a brief stress reduction
exercise and ends with a brief cognitive restructuring imagery exercise. The main portion of
the meeting emphasizes providing an environment in which patients can share their concerns,
feelings, and thoughts openly and honestly. The role of the cotherapist is to facilitate
expression of patients' concerns, offer empathy, and continue to encourage patients to
express their feelings and thoughts.
Quality-of-life questionnaires are filled out at 3 and 6 months and then every 6 months for
a total of 2 years.
PROJECTED ACCRUAL: Approximately 480 patients (including an estimated 53 minority patients)
will be entered in this multicenter study.
Gary R. Morrow, PhD, MS
James P. Wilmot Cancer Center
United States: Federal Government
|CCOP - Wichita||Wichita, Kansas 67214-3882|
|CCOP - Kalamazoo||Kalamazoo, Michigan 49007-3731|
|CCOP - Columbus||Columbus, Ohio 43206|
|CCOP - Western Regional, Arizona||Phoenix, Arizona 85006-2726|
|CCOP - Northwest||Tacoma, Washington 98405-0986|
|Stanford Cancer Center at Stanford University Medical Center||Stanford, California 94305|
|James P. Wilmot Cancer Center at University of Rochester Medical Center||Rochester, New York 14642|